BofA Securities Starts Ligand Pharma (LGND) at Buy

March 11, 2026 6:03 AM

BofA Securities analyst Jason Zemansky initiates coverage on Ligand Pharma ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found